Ryan Miyamoto 
Early in the spring, SAA creates a dedicated hub on our website with informational and supportive resources on COVID-19, developing numerous articles, interviews, and live-webinars providing our community access to the specific information and resources they urgently need.
SAA, in partnership with members of its Medical and Scientific Advisory Board, launches the only research survey of its kind to study the possible impact spondyloarthritis, and medications used for spondyloarthritis, may have on COVID-19.
